SCTX · MRNA in the 13F filings
Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.
Holders over time
Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
- SCTX
- MRNA
| Quarter | SCTX | MRNA |
|---|---|---|
| Q4 2020 | none listed holders, n.a. | 16 holders, $4.4bn |
| Q1 2021 | none listed holders, n.a. | 18 holders, $8.0bn |
| Q2 2021 | none listed holders, n.a. | 22 holders, $18.4bn |
| Q3 2021 | none listed holders, n.a. | 27 holders, $27.6bn |
| Q4 2021 | none listed holders, n.a. | 20 holders, $17.2bn |
| Q1 2022 | none listed holders, n.a. | 16 holders, $11.8bn |
| Q2 2022 | none listed holders, n.a. | 19 holders, $10.2bn |
| Q3 2022 | none listed holders, n.a. | 22 holders, $8.4bn |
| Q4 2022 | none listed holders, n.a. | 20 holders, $13.0bn |
| Q1 2023 | none listed holders, n.a. | 17 holders, $11.2bn |
| Q2 2023 | none listed holders, n.a. | 15 holders, $8.9bn |
| Q3 2023 | none listed holders, n.a. | 12 holders, $7.2bn |
| Q4 2023 | none listed holders, n.a. | 8 holders, $6.9bn |
| Q1 2024 | none listed holders, n.a. | 7 holders, $7.6bn |
| Q2 2024 | none listed holders, n.a. | 13 holders, $9.5bn |
| Q3 2024 | none listed holders, n.a. | 12 holders, $4.8bn |
| Q4 2024 | none listed holders, n.a. | 15 holders, $3.1bn |
| Q1 2025 | none listed holders, n.a. | 11 holders, $2.0bn |
| Q2 2025 | none listed holders, n.a. | 10 holders, $2.0bn |
| Q3 2025 | none listed holders, n.a. | 9 holders, $1.2bn |
| Q4 2025 | none listed holders, n.a. | 10 holders, $2.5bn |
| Q1 2026 | none listed holders, n.a. | 9 holders, $4.8bn |
| Q2 2026 | none listed holders, n.a. | 9 holders, $8.0bn |
| Q3 2026 | 2 holders, $21m | 17 holders, $22.4bn |
SCTX
Scribe Therapeutics Inc
- Holders
- 0
- Reported value
- $0
- Buyers
- n.a.
- Sellers
- n.a.
No cross-section for this quarter.
MRNA
Moderna Inc
- Holders
- 9
- Reported value
- $4.8bn
- Buyers
- 17
- Sellers
- 19
Breadth -2 among 91 comparable managers.
Who holds both, Q1 2026
Among the 9 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.
Both (0)
No tracked manager lists every one of them.
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.